David Schenkein, Director at Agios Pharma, holds 472.71K shares in Agios Pharma (Ticker: AGIO), holds 72.99K shares in Denali Therapeutics (Ticker: DNLI), holds ― shares in Prime Medicine, Inc. (Ticker: PRME). Most recently, David Schenkein Sold ― shares of Agios Pharma on Feb 29, 2024 for an estimated value of 2.40M.